On-demand webinar on PAT solutions in scale-up and scale-down in biopharma.

活动概述

Effective models for scale-up and scale-down
Root-cause analysis in biopharma
The role of leading-edge process analytics

Efficiency, Consistency, and Reliability

The need for novel biopharmaceuticals is ever-growing. To meet demand, biopharma companies are expanding their production pipelines to greater industrial scales. Companies have also been pushing towards higher yield and productivity rates by shifting gears on biomanufacturing floors towards fed-batch and perfusion in single-use platforms, especially in cell-culture expression systems.

Long before all these novel biomanufacturing developments were at hand, bioprocess engineers knew that the highest titers and productivity rates can only be achieved by effective scale-up models. They’ve also known that the number of batch losses cannot be minimized without an economical and robust scale-down model.

But where do uniform, intelligent, and reliably precise Process Analytical Technology (PAT) solutions stand in achieving these objectives? The answer is at the very pinnacle of both scale-up and scale-down models.

Watch our webinar where we review what goes into effective models for scale-up and down, and dive deep into how today’s novel PAT solutions are making a clear mark in this area.

Speakers

Dr. Ehsan Mahdinia

METTLER TOLEDO Process Analytics

Ehsan holds a Ph.D. in Microbiological Engineering awarded by the Agricultural and Biological Engineering Department of the Pennsylvania State University. He holds a Master’s Degree in Biotechnology from the Department of Chemical and Petroleum Engineering of the Sharif University of Technology in Tehran, Iran. Previously, he was Director of the Masters of Biomanufacturing & Bioprocessing program at the Stack Family Center for Biopharmaceutical Education & Training (CBET), where he also helped lay the foundation as one of the founding faculty members for CBET. Ehsan, simultaneously served as an Assistant Professor at the Departments of Basic & Clinical Sciences and Pharmaceutical Sciences at the Albany College of Pharmacy and Health Sciences. Dr. Mahdinia also worked as Associate Editor for the Journal of Molecular Biotechnology-Springer.